Marshall Wace North America’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q2 | – | Sell |
-97,635
| Closed | -$4.62M | – | 1646 |
|
2021
Q1 | $4.62M | Buy |
+97,635
| New | +$4.62M | 0.02% | 583 |
|
2020
Q3 | – | Sell |
-16,908
| Closed | -$858K | – | 1426 |
|
2020
Q2 | $858K | Buy |
+16,908
| New | +$858K | 0.01% | 795 |
|
2020
Q1 | – | Sell |
-2,509
| Closed | -$120K | – | 1525 |
|
2019
Q4 | $120K | Buy |
+2,509
| New | +$120K | ﹤0.01% | 1039 |
|
2019
Q2 | – | Sell |
-662,587
| Closed | -$24.9M | – | 1528 |
|
2019
Q1 | $24.9M | Buy |
662,587
+293,495
| +80% | +$11M | 0.18% | 123 |
|
2018
Q4 | $12.7M | Sell |
369,092
-73,768
| -17% | -$2.53M | 0.12% | 145 |
|
2018
Q3 | $20.8M | Sell |
442,860
-1,267,114
| -74% | -$59.6M | 0.14% | 137 |
|
2018
Q2 | $57.7M | Buy |
1,709,974
+1,048,803
| +159% | +$35.4M | 0.33% | 71 |
|
2018
Q1 | $17.9M | Buy |
+661,171
| New | +$17.9M | 0.09% | 261 |
|
2017
Q4 | – | Sell |
-61,745
| Closed | -$1.24M | – | 1562 |
|
2017
Q3 | $1.24M | Buy |
+61,745
| New | +$1.24M | 0.01% | 904 |
|
2013
Q4 | $373K | Buy |
22,000
+2,000
| +10% | +$33.9K | 0.01% | 566 |
|
2013
Q3 | $429K | Buy |
+20,000
| New | +$429K | 0.01% | 468 |
|